Piali L - Search Results

1

Cenerimod, a novel selective S1P₁ receptor modulator with unique signaling properties.

Piali L, Birker-Robaczewska M, Lescop C, Froidevaux S, Schmitz N, Morrison K, Kohl C, Rey M, Studer R, Vezzali E, Hess P, Clozel M, Steiner B, Bolli MH, Nayler O. Piali L, et al. Pharmacol Res Perspect. 2017 Dec;5(6):e00370. doi: 10.1002/prp2.370. Pharmacol Res Perspect. 2017. PMID: 29226621 Free PMC article.

2

The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.

Piali L, Froidevaux S, Hess P, Nayler O, Bolli MH, Schlosser E, Kohl C, Steiner B, Clozel M. Piali L, et al. J Pharmacol Exp Ther. 2011 May;337(2):547-56. doi: 10.1124/jpet.110.176487. Epub 2011 Feb 23. J Pharmacol Exp Ther. 2011. PMID: 21345969

3

Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes.

You S, Piali L, Kuhn C, Steiner B, Sauvaget V, Valette F, Clozel M, Bach JF, Chatenoud L. You S, et al. Among authors: piali l. PLoS One. 2013 Oct 24;8(10):e77296. doi: 10.1371/journal.pone.0077296. eCollection 2013. PLoS One. 2013. PMID: 24204793 Free PMC article.

4

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis.

Pouzol L, Piali L, Bernard CC, Martinic MM, Steiner B, Clozel M. Pouzol L, et al. Among authors: piali l. Innov Clin Neurosci. 2019 Mar 1;16(3-4):22-30. Innov Clin Neurosci. 2019. PMID: 31214480 Free PMC article.

5

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases.

Meyer EA, Äänismaa P, Froidevaux S, Keller M, Piali L, Caroff E. Meyer EA, et al. Among authors: piali l. J Med Chem. 2022 Sep 8;65(17):11513-11532. doi: 10.1021/acs.jmedchem.2c00675. Epub 2022 Aug 10. J Med Chem. 2022. PMID: 35947786

6

Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125.

Caroff E, Meyer EA, Äänismaa P, Froidevaux S, Keller M, Piali L. Caroff E, et al. Among authors: piali l. J Med Chem. 2022 Sep 8;65(17):11533-11549. doi: 10.1021/acs.jmedchem.2c00676. Epub 2022 Aug 15. J Med Chem. 2022. PMID: 35969159

7

Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice.

Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD, Gill J, Boyd R, Sussman DJ, Holländer GA. Balciunaite G, et al. Among authors: piali l. Nat Immunol. 2002 Nov;3(11):1102-8. doi: 10.1038/ni850. Epub 2002 Oct 15. Nat Immunol. 2002. PMID: 12379851 Free article.

8

Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.

Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Holländer GA, Piali L. Frigerio S, et al. Among authors: piali l. Nat Med. 2002 Dec;8(12):1414-20. doi: 10.1038/nm1202-792. Epub 2002 Nov 4. Nat Med. 2002. PMID: 12415259

9

The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, Moser B. Piali L, et al. Eur J Immunol. 1998 Mar;28(3):961-72. doi: 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4. Eur J Immunol. 1998. PMID: 9541591 Free article.

10

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Loetscher M, et al. Among authors: piali l. J Exp Med. 1996 Sep 1;184(3):963-9. doi: 10.1084/jem.184.3.963. J Exp Med. 1996. PMID: 9064356 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page